Nanoform Finland Ltd, Booth 17 [ company website ]

Our multi-patented Controlled Expansion of Supercritical Solutions (CESS^TM) technology enables the creation of API nanoparticles directly from solution. The process can be applied to most small molecules, with a high success rate of 80-90%.

Novasep, Booth 46

Novasep provides flexible contract development & manufacturing (CDMO) solutions for Small Molecule APIs & Biopharmaceuticals to innovators. We offer a wide range of flexible cGMP manufacturing assets on multiple sites with an outstanding regulatory track record.

We are a world leader in a number of technologies including industrial chromatography (batch and continuous), hazardous & cryogenic chemistry, HPAPIs, ADCs & Viral Vectors.  

Novasep has recently invested over >100m€ to expand its commercial manufacturing footprint including:

> ADCs: A new 11m€ bioconjugation unit in Le Mans, France

> Viral Vectors: Senrise-IV, a new 27m€ facility for AAV, Adenovirus, Lentiviral vectors, HSV... in Seneffe, Belgium

> Fill & Finish: Senefill, a new 10m€ facility for aseptic Fill & Finish operations for viral vectors, viruses, plasmids and other biologics in Seneffe, Belgium

Have a look at our website to learn more about our services: www.novasep.com

And to contact us: novasep@novasep.com